• Home
  • Pharmaceuticals and Healthcare
Dynamics in Post-pandemic Global Blood-Brain Barrier Transport Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Blood-Brain Barrier Transport Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ779450 | No. of Pages: 159 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Jun-2021 
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Blood-Brain Barrier Transport Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Blood-Brain Barrier Transport Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Carrier-mediated Transport

Receptor-mediated Transport

Absorptive-mediated Transport

Active Efflux Transport

Others

Segmented by End User/Segment
Alzheimer's Disease

Epilepsy

Parkinson's Disease

Multiple Sclerosis

Hunter's Syndrome

Brain Cancer

Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Palobiofarma

NewGen Therapeutics

Minoryx

Immune Pharmaceuticals

Fondazione Telethon

Fluorinov Pharma

EIP Pharma

Dainippon Sumitomo Pharma

Cyclenium

CarThera

BrainsGate

Bioasis

BioAdvance

Bach Pharma

AZ Therapies



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Blood-Brain Barrier Transport Drugs Market Status and Forecast (2016-2027)
        1.3.2 Global Blood-Brain Barrier Transport Drugs Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Blood-Brain Barrier Transport Drugs Supply by Company
    2.1 Global Blood-Brain Barrier Transport Drugs Sales Volume by Company
    2.2 Global Blood-Brain Barrier Transport Drugs Sales Value by Company
    2.3 Global Blood-Brain Barrier Transport Drugs Price by Company
    2.4 Blood-Brain Barrier Transport Drugs Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Blood-Brain Barrier Transport Drugs Market Status by Category
    3.1 Blood-Brain Barrier Transport Drugs Category Introduction
        3.1.1 Carrier-mediated Transport

        3.1.2 Receptor-mediated Transport

        3.1.3 Absorptive-mediated Transport

        3.1.4 Active Efflux Transport

        3.1.5 Others
    3.2 Global Blood-Brain Barrier Transport Drugs Market by Category
        3.2.1 Global Blood-Brain Barrier Transport Drugs Sales Volume by Category (2016-2021)
        3.2.2 Global Blood-Brain Barrier Transport Drugs Sales Value by Category (2016-2021)
        3.2.3 Global Blood-Brain Barrier Transport Drugs Price by Category (2016-2021)
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional Blood-Brain Barrier Transport Drugs Market Status by End User/Segment
    4.1 Blood-Brain Barrier Transport Drugs Segment by End User/Segment
        4.1.1 Alzheimer's Disease

        4.1.2 Epilepsy

        4.1.3 Parkinson's Disease

        4.1.4 Multiple Sclerosis

        4.1.5 Hunter's Syndrome

        4.1.6 Brain Cancer

        4.1.7 Others
    4.2 Global Blood-Brain Barrier Transport Drugs Market by End User/Segment
        4.2.1 Global Blood-Brain Barrier Transport Drugs Sales Volume by End User/Segment (2016-2021)
        4.2.2 Global Blood-Brain Barrier Transport Drugs Sales Value by End User/Segment (2016-2021)
        4.2.3 Global Blood-Brain Barrier Transport Drugs Price by End User/Segment (2016-2021)
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global Blood-Brain Barrier Transport Drugs Market Status by Region
    5.1 Global Blood-Brain Barrier Transport Drugs Market by Region
        5.1.1 Global Blood-Brain Barrier Transport Drugs Sales Volume by Region
        5.1.2 Global Blood-Brain Barrier Transport Drugs Sales Value by Region
    5.2 North America Blood-Brain Barrier Transport Drugs Market Status
    5.3 Europe Blood-Brain Barrier Transport Drugs Market Status
    5.4 Asia Pacific Blood-Brain Barrier Transport Drugs Market Status
    5.5 Central & South America Blood-Brain Barrier Transport Drugs Market Status
    5.6 Middle East & Africa Blood-Brain Barrier Transport Drugs Market Status
6 North America Blood-Brain Barrier Transport Drugs Market Status
    6.1 North America Blood-Brain Barrier Transport Drugs Market by Country
        6.1.1 North America Blood-Brain Barrier Transport Drugs Sales Volume by Country (2016-2021)
        6.1.2 North America Blood-Brain Barrier Transport Drugs Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Blood-Brain Barrier Transport Drugs Market Status
    7.1 Europe Blood-Brain Barrier Transport Drugs Market by Country
        7.1.1 Europe Blood-Brain Barrier Transport Drugs Sales Volume by Country (2016-2021)
        7.1.2 Europe Blood-Brain Barrier Transport Drugs Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Blood-Brain Barrier Transport Drugs Market Status
   8.1 Asia Pacific Blood-Brain Barrier Transport Drugs Market by Country
        8.1.1 Asia Pacific Blood-Brain Barrier Transport Drugs Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific Blood-Brain Barrier Transport Drugs Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Blood-Brain Barrier Transport Drugs Market Status
    9.1 Central & South America Blood-Brain Barrier Transport Drugs Market by Country
        9.1.1 Central & South America Blood-Brain Barrier Transport Drugs Sales Volume by Country (2016-2021)
        9.1.2 Central & South America Blood-Brain Barrier Transport Drugs Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Blood-Brain Barrier Transport Drugs Market Status
    10.1 Middle East & Africa Blood-Brain Barrier Transport Drugs Market by Country
        10.1.1 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Blood-Brain Barrier Transport Drugs Manufacturing Cost Analysis
    11.5 Blood-Brain Barrier Transport Drugs Sales Channel and Distributors Analysis
        11.5.1 Blood-Brain Barrier Transport Drugs Sales Channel
        11.5.2 Blood-Brain Barrier Transport Drugs Distributors
    11.6 Blood-Brain Barrier Transport Drugs Downstream Major Buyers
12 Global Blood-Brain Barrier Transport Drugs Market Forecast by Category and by End User/Segment
    12.1 Global Blood-Brain Barrier Transport Drugs Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global Blood-Brain Barrier Transport Drugs Forecast by Category
        12.2.1 Global Blood-Brain Barrier Transport Drugs Sales Volume Forecast by Category
        12.2.2 Global Blood-Brain Barrier Transport Drugs Sales Value Forecast by Category
        12.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Category
    12.3 Global Blood-Brain Barrier Transport Drugs Forecast by End User/Segment
        12.3.1 Global Blood-Brain Barrier Transport Drugs Sales Volume Forecast by End User/Segment
        12.3.2 Global Blood-Brain Barrier Transport Drugs Sales Value Forecast by End User/Segment
        12.3.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by End User/Segment
13 Global Blood-Brain Barrier Transport Drugs Market Forecast by Region/Country
    13.1 Global Blood-Brain Barrier Transport Drugs Market Forecast by Region (2022-2027)
        13.1.1 Global Blood-Brain Barrier Transport Drugs Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global Blood-Brain Barrier Transport Drugs Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Palobiofarma

        14.1.1 Company Information
        14.1.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.1.3 Palobiofarma
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 NewGen Therapeutics

        14.2.1 Company Information
        14.2.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.2.3 NewGen Therapeutics
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 Minoryx

        14.3.1 Company Information
        14.3.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.3.3 Minoryx
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Immune Pharmaceuticals

        14.4.1 Company Information
        14.4.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.4.3 Immune Pharmaceuticals
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Fondazione Telethon

        14.5.1 Company Information
        14.5.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.5.3 Fondazione Telethon
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Fluorinov Pharma

        14.6.1 Company Information
        14.6.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.6.3 Fluorinov Pharma
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.6.4 SWOT Analysis
    14.7 EIP Pharma

        14.7.1 Company Information
        14.7.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.7.3 EIP Pharma
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.7.4 SWOT Analysis
    14.8 Dainippon Sumitomo Pharma

        14.8.1 Company Information
        14.8.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.8.3 Dainippon Sumitomo Pharma
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.8.4 SWOT Analysis
    14.9 Cyclenium

        14.9.1 Company Information
        14.9.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.9.3 Cyclenium
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.9.4 SWOT Analysis
    14.10 CarThera

        14.10.1 Company Information
        14.10.2 Blood-Brain Barrier Transport Drugs Product Introduction
        14.10.3 CarThera
 Blood-Brain Barrier Transport Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.10.4 SWOT Analysis
    14.11 BrainsGate

    14.12 Bioasis

    14.13 BioAdvance

    14.14 Bach Pharma

    14.15 AZ Therapies

15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com